Capital Research Global Investors
OM icon

Capital Research Global Investors’s Outset Medical OM Stock Holding History

Capital Research Global Investors’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8,540
Closed -$6.41M – 426
2020
Q3 		$6.41M Buy
+8,540
New +$7.01M ﹤0.01% 386

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Capital Research Global Investors's OM Position: Q4 2020 in Review

Capital Research Global Investors sold out of Outset Medical (OM) in Q4 2020, closing a stake of 8,540 shares — an estimated $6.41M sold.

Capital Research Global Investors first reported a position in OM in Q3 2020 and held it in 1 quarter. The position peaked at $6.41M in Q3 2020. 111 funds tracked by Wall St. Rank hold OM as of Q4 2020.

  • Capital Research Global Investors reported no remaining Outset Medical position as of Q4 2020 after selling out during the quarter.
  • Capital Research Global Investors sold 8,540 Outset Medical shares in Q4 2020, an estimated $6.41M.
  • Capital Research Global Investors first reported a position in Outset Medical in Q3 2020 and held it in 1 quarter.
  • Capital Research Global Investors's Outset Medical position peaked at $6.41M in Q3 2020.
  • 111 funds tracked by Wall St. Rank held Outset Medical as of Q4 2020.

Based on Capital Research Global Investors's 13F filing for Q4 2020, filed 12 Feb 2021.